Iovance Biotherapeutics and Adaptimmune brought first-of-their-kind cell therapy cancer treatments to market. Others had to ...

Two former internet messageboard darlings that fell from grace a few years ago have been the year's biggest winners on the ...

If you invested $10,000 in Australia's best-performing stock a year ago would have turned that into a $46,400 bonanza. Here's ...

Morgans's healthcare analyst Iain Wilkie describes 2024 as "pretty patchy" for the ASX healthcare sector, which has ...

Medicus Pharma Ltd. has announced a change in its auditing firm, with MNP LLP resigning and EisnerAmper LLP being appointed as the new auditor. The transition, effective December 19, 2024, was ...

Brookline Capital Markets initiated coverage of Medicus Pharma (MDCX) with a buy rating, citing the potential of its basal ...

Medicus Pharma Ltd (MDCX) has received a new Buy rating, initiated by Brookline Capital Markets analyst, Kumaraguru Raja.Don't Miss Our ...

The Market Online speaks with Medicus Pharma Executive Chairman & CEO, Raza Bokhari, MD as Medicus Pharma Ltd. Announces ...

Kogan.Com (KGN), Nick Scali (NCK), Orthocell (OCC), Pro Medicus (PME), Perenti (PRN), Qantas (QAN), Redox (RDX), Solvar (SVR) ...

Ciaruffoli serves on numerous for-profit and nonprofit boards, including Chair of the Audit Committee of Medicus Pharma Ltd., ...

McKinsey & Co. will pay $650 million in penalties to the U.S. Department of Justice (DOJ) to settle charges that it advised Purdue Pharma on how to “turbocharge” the sale of Oxycontin in the middle of ...